Tianhong Guozheng Biomedical Trading Open Index Securities Investment Fund Initiated Feeder Fund (hereinafter referred to as: Tianhong Guozheng Biomedical ETF Initiated Feeder C, code 011041) announced its latest net value on August 7, down 3.07 percent.

Tianhong Guozheng Biopharmaceutical ETF Initiated Link C was established on January 27, 2021, and the performance comparison benchmark is Guozheng Biopharmaceutical Index yield x 95% + bank demand deposit rate (after tax) x 5%. The fund has gained -49.17 per cent since its inception, -18.41 per cent this year, 2.96 per cent in the past month and -25.87 per cent in the past year. For nearly a year, the fund ranked 2557/2768 in its class.

The fund manager is Shachuan, He Yuxuan. Shachuan has managed (or proposed to manage) the fund since December 22, 2020, with a gain of -49.17 during his tenure; He Yuxuan has managed (or proposed to manage) the fund since July 1, 2021, with a gain of -54.11 during his tenure.

According to the latest periodic report, the top ten stocks of the fund are as follows:

td>20500> Tiger Medicine

Stock Code	Stock Name	Position Percentage		Market value of holdings (CNY)
	002252	0.55		890400	6.6869 million
002007			0.54	297100	6.658 million
603259		0.49	95694	5.9627 million	>
301207	Hualan vaccine	0.47	172400	5.734 million
000661		Changchun Hi-Tech	0.23	2.7942 million
	300896		0.20	5500	2.4472 million
300347		0.19	36800	2.3751 million
	688363	Huaxi Bio	0.14%	19000	1.694 million
002821			0.14%	14400	1.6972 million
300122		0.11%/td>	31217		1.3798 million

Now I send you a red envelope of 60 yuan, direct cash withdrawal is not routine. Please participate in the activity to receive it.